Mayinglong Pharmaceutical Group Co Ltd (600993) — Cash Flow Reinvestment Rate
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Cash Flow Reinvestment Rate of 0.10x as of September 2025, reinvesting CN¥13.73 Million (capex CN¥13.73 Million ) from operating cash flow of CN¥139.20 Million. Check cash flow quality index of Mayinglong Pharmaceutical Group Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Mayinglong Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Mayinglong Pharmaceutical Group Co Ltd across 22 annual periods. Explore Mayinglong Pharmaceutical Group Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Mayinglong Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see Mayinglong Pharmaceutical Group Co Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.44x | CN¥862.67 Million | CN¥600.44 Million | CN¥119.37 Million | ▲ +170.2% |
| 2024 | 0.53x | CN¥264.57 Million | CN¥497.61 Million | CN¥203.85 Million | ▼ -53.9% |
| 2023 | 1.15x | CN¥696.64 Million | CN¥604.07 Million | CN¥248.36 Million | ▼ -43.2% |
| 2022 | 2.03x | CN¥693.77 Million | CN¥341.85 Million | CN¥75.01 Million | ▲ +1091.8% |
| 2021 | 0.17x | CN¥101.69 Million | CN¥597.17 Million | CN¥65.10 Million | ▼ -86.8% |
| 2020 | 1.29x | CN¥365.76 Million | CN¥282.99 Million | CN¥45.41 Million | ▲ +746.3% |
| 2019 | 0.15x | CN¥75.07 Million | CN¥491.58 Million | CN¥46.36 Million | ▼ -28.2% |
| 2018 | 0.21x | CN¥65.52 Million | CN¥308.24 Million | CN¥24.96 Million | ▼ -43.1% |
| 2017 | 0.37x | CN¥133.13 Million | CN¥356.17 Million | CN¥41.91 Million | ▼ -74.6% |
| 2016 | 1.47x | CN¥352.23 Million | CN¥239.60 Million | CN¥65.24 Million | ▼ -5.7% |
| 2015 | 1.56x | CN¥285.18 Million | CN¥182.85 Million | CN¥123.93 Million | ▲ +63.0% |
| 2014 | 0.96x | CN¥106.87 Million | CN¥111.67 Million | CN¥106.87 Million | ▲ +48.6% |
| 2013 | 0.64x | CN¥83.68 Million | CN¥129.94 Million | CN¥83.68 Million | ▲ +232.8% |
| 2012 | 0.19x | CN¥32.75 Million | CN¥169.25 Million | CN¥32.75 Million | ▼ -67.4% |
| 2011 | 0.59x | CN¥44.69 Million | CN¥75.37 Million | CN¥44.69 Million | ▲ +266.9% |
| 2009 | 0.16x | CN¥34.93 Million | CN¥216.11 Million | CN¥34.93 Million | ▼ -49.5% |
| 2008 | 0.32x | CN¥32.84 Million | CN¥102.59 Million | CN¥32.84 Million | ▼ -91.6% |
| 2007 | 3.80x | CN¥24.65 Million | CN¥6.49 Million | CN¥24.65 Million | ▲ +1242.0% |
| 2006 | 0.28x | CN¥21.32 Million | CN¥75.27 Million | CN¥21.32 Million | ▼ -54.0% |
| 2005 | 0.62x | CN¥35.95 Million | CN¥58.43 Million | CN¥35.95 Million | ▲ +15.2% |
| 2004 | 0.53x | CN¥28.94 Million | CN¥54.19 Million | CN¥28.94 Million | ▲ +148.1% |
| 2003 | 0.22x | CN¥14.54 Million | CN¥67.52 Million | CN¥14.54 Million | — |